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In the chain of events by which chemotactic peptides stimulate NADPH oxidase-catalyzed superoxide for- 
mation in human neutrophils, the involvements of a pertussis toxin-sensitive guanine nucleotide-binding 
protein (N-protein), mobilization of intracellular calcium and protein kinase C stimulation have been pro- 
posed. Superoxide formation was studied in membranes from human neutrophils; NADPH oxidase was 
stimulated by arachidonic acid in the presence of neutrophil cytosol. Fluoride and stable GTP analogues. 
such as GTPyS and GppNHp, which all activate N-proteins, enhanced NADPH oxidase activity up to 4- 
fold. GDPPS inhibited the effect of GTPyS. These data suggest that NADPH oxidase is regulated by an 
N-protein, independent of an elevation of the cytoplasmic calcium concentration. 
Neutrophil NADPH oxidase Guanine nucleotide-binding protein Arachidonic acid 
1. INTRODUCTION 
Binding of the chemotactic peptide, FMLP, to 
neutrophil membrane receptors induces several 
cellular responses including superoxide formation 
[l], release of arachidonic acid, phospholipase C- 
catalyzed degradation of phosphatidylinositol 
4,5bisphosphate to diacylglycerol and inositol 
1,4,5_trisphosphate as well as mobilization of in- 
tracellular calcium [2,3]. All these FMLP-induced 
events involve a pertussis toxin-sensitive N-protein 
[2-41. As PMA, which is an activator of protein 
kinase C, stimulates NADPH oxidase in intact 
neutrophils [ 11, it is widely assumed that activation 
Abbreviations: AppNHp, adenylyl imidodiphos- 
phate; ATPyS, adenosine 5’-0-(3-thiotriphosphate); 
FMLP, N-formyl-L-methionyl-L-leucyl-L-phenylala- 
nine; GDP,&S, guanosine 5’-0-(2-thiodiphosphate); 
GppNHp, guanylyl imidodiphosphate; GTPrS, gua- 
nosine 5 ’ -0-(3-thiotriphosphate); N-protein, guanine 
nucleotide-binding protein; PMA, phorbol 12-myristate 
13-acetate 
of NADPH oxidase is mediated by protein kinase 
C-catalyzed phosphorylation of the oxidase or a 
regulatory component [ 1,5]. There is recent 
evidence indicating that NADPH oxidase activa- 
tion by FMLP may not necessarily be linked to 
phosphoinositide turnover or activation of protein 
kinase C, as a transient increase in the intracellular 
calcium concentration is not sufficient for FMLP- 
induced NADPH oxidase activation [6]. In addi- 
tion, inhibitors of protein kinase C block PMA- 
but not FMLP-induced superoxide formation 
[7,8]. Furthermore, in calcium-depleted human 
neutrophils primed with subthreshold concentra- 
tions of PMA, FMLP activates NADPH oxidase 
in the absence of phosphoinositide hydrolysis [9]. 
We studied the regulation of NADPH oxidase in 
membranes from unstimulated human 
neutrophils. These investigations were prompted 
by the finding that arachidonic acid activates 
superoxide formation in a cell-free system con- 
sisting of the particulate 48 000 x g fraction and the 
cytosolic fraction from human neutrophils [lo]. 
We report here that stable GTP analogues 
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stimulate NADPH oxidase activity, suggesting the 
direct involvement of an N-protein in the regula- 
tion of this enzyme. 
2. MATERIALS AND METHODS 
Human neutrophils were isolated by dextran 
sedimentation and centrifugation through Ficoll- 
Hypaque (Biochrom, Berlin) and disrupted by 
nitrogen cavitation. Neutrophil membranes and 
cytosol were isolated by centrifugation on discon- 
tinuous Percoll gradients (Pharmacia, Uppsala) 
[ll], harvested and stored at -80°C. 
NADPH oxidase activity of neutrophil mem- 
branes was determined by measuring the linear rate 
of superoxide dismutase-inhibitable fer- 
ricytochrome c reduction at 27.5”C [lo]. The assay 
mixture (500~1) contained 2-7 pg neutrophil mem- 
brane protein, 30-17Opg cytosolic protein, 500/M 
NADPH, 10pM FAD, 100pM ferricytochrome c, 
3.4 mM MgC12, 200rM ATP, 500pM EGTA and 
50 mM triethanolamine-HCI, pH 7.0. Although 
the specific activity of NADPH oxidase varied to 
some extent between membrane preparations as 
observed by Jones et al. [12], qualitatively com- 
parable results were obtained in all preparations 
analyzed. 
For pertussis toxin treatment of neutrophils, 
purified neutrophils were suspended at 8 x 10’ 
cells/ml in carbogen-saturated buffer (138 mM 
NaCl, 6 mM KCl, 1 mM MgS04, 1.1 mM CaCl2, 
0.1 mM EDTA, 1 mM Na2HP04,5 mM NaHCO3, 
5.5 mM glucose, and 20 mM Hepes, pH 7.4) and 
incubated for 3 h at 37°C with pertussis toxin (1 
pg/ml) or its carrier. Cells were then washed twice 
in the same buffer, and membranes were isolated. 
Protein determination was performed according 
to Lowry et al. [13]. NADPH, FAD, guanine and 
adenine nucleotides were from Boehringer 
Mannheim (Mannheim, FRG). Ferricytochrome c 
(Type III), superoxide dismutase and arachidonic 
acid (grade I, 99% pure, from porcine liver) were 
obtained from Sigma (Taufkirchen, FRG). A stock 
solution of 16 mM arachidonic acid in 100% 
ethanol was prepared under nitrogen and stored at 
- 20°C. 
3. RESULTS 
Original registrations of superoxide formation 
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are shown in fig.1. Arachidonic acid (16 PM) 
stimulated superoxide generation in neutrophil 
membranes in the presence of neutrophil cytosol; 
there was a lag time of l-4 min from addition of 
arachidonic acid to reaching a constant rate of 
superoxide formation, depending on the mem- 
brane preparation used. In the absence of 
neutrophil cytosol, NADPH oxidase was not ac- 
tivated by arachidonic acid. Addition of the stable 
GTP analogue, GTPyS (10 PM), which activates 
N-proteins [ 141, 2 min prior to or with arachidonic 
acid enhanced the rate of superoxide production 
about 3-fold. 
This effect was specific for non-hydrolyzable 
GTP analogues (fig.2). GTPys and GppNHp 
stimulated superoxide formation about 4-fold; the 
effect of GTPyS was half-maximal at 1 PM, 
GppNHp was 2 orders of magnitude less potent. 
GTP, ATPyS and AppNHp at up to 3OOpM had 
no effect. GDP@ did not stimulate NADPH ox- 
idase activity but competitively inhibited the 
stimulatory effect of GTP+ (fig.3): 10 PM 
GDPflS caused half-maximal inhibition of the 
superoxide formation observed in the presence of 
1 PM GTPyS. Fluoride, which ‘is another potent 
activator of N-proteins [ 141, activates superoxide 
generation [ 151 and calcium mobilization [ 161 in 
intact neutrophils. In the presence of aluminium (5 
,zM Al2(SG4)3), which is necessary for fluoride ac- 
tivation of N-proteins [17], fluoride (10 mM) 
enhanced NADPH oxidase activity about 4-fold, 
an effect comparable to that obtained with the 
/ / 
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Fig.1. Time courses of superoxide generation in human 
neutrophil membranes. Superoxide formation was deter- 
mined with 2,~g membrane protein in the presence of 30 
pg neutrophil cytosol. The intersection of the dashed 
lines represents the lag time required for NADPH ox- 
idase activation, defined from extrapolation of the ab- 
sorbance curve to zero. AA indicates addition of 
arachidonic acid (16 PM), GTP$S the addition of 
GTPyS (10 PM). 
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Fig.2. Influence of guanine and adenine nucleotides and 
of fluoride on NADPH oxidase activity. Upper panel: 
nucleotides were added to the assay mixture, containing 
2 pg membrane protein and 30 ,ug cytosolic protein, 2 
min prior to arachidonic acid (16 PM). Data represent 
the means + SE of 3 determinations. (M) GTPrS, 
(o---o) GPPNHP, (-) GTP, (--) ATP+, 
(M) AppNHp. Lower panel: NaF at the indicated 
concentrations and 5 PM Alz(SO& were added prior to 
arachidonic acid (16 pM). The assays contained 2 pg 
membrane protein and 30 gg cytosol protein. Data are 
the means k SE of 6 determinations. 
Fig.3. Influence of GDPflS on NADPH oxidase activity 
in neutrophil membranes. GDP@ was added at the in- 
dicated concentrations without (O--O) and with con- 
comitant addition of 1 gM GTPyS (M) 2 min prior 
to arachidonic acid (16 FM). The assays contained 2 pg 
membrane protein and 3Opg cytosolic protein. Data are 
the means + SE of 3 determinations. 
non-hydrolyzable GTP analogues (see (fig.2). 
It was recently shown that NADPH oxidase in 
neutrophil membranes is stimulated by 
arachidonic acid in the presence of neutrophil 
cytosol [lo]. We report here that this stimulation 
of the enzyme is increased several-fold by stable 
GTP analogues and fluoride, known stimulators 
of N-proteins. The present findings suggest hat 
NADPI-I oxidase represents a new N-protein- 
regulated effector system. The oxidase represents 
the first N-protein-controlled enzyme that can be 
monitored by a photometric method. 
In analogy to the adenylate cyclase system [18], In contrast to the current opinion that 
the stimulatory effect of GTPyS was not reduced chemotactic peptides indirectly stimulate NADPH 
in membranes obtained from neutrophils oxidase in the course of neutrophil activation [l], 
pretreated with pertussis toxin (fig.4). In contrast our results suggest a more direct involvement of an 
to the adenylate cyclase system, in which the ef- N-protein in the regulation of NADPH oxidase. 
fects of GTPyS are significantly delayed following The identity of the cytosolic cofactor required for 
pertussis toxin treatment, the lag time required for NADPH oxidase activation in neutrophil mem- 
NADPH oxidase activation by arachidonic acid branes and the mechanism by which arachidonic 
and GTPyS in membranes from pertussis toxin- 
treated neutrophils was not changed. 
4. DISCUSSION 
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Fig.4. Effect of GTPyS on NADPH oxidase activity in 
membranes obtained from pertussis toxin-treated 
neutrophils. GTPyS was added to membranes obtained 
from neutrophils treated with pertussis toxin or its car- 
rier. The assay mixture contained 7 pg membrane pro- 
tein and 170 pg cytosolic protein; the reaction was 
started with arachidonic acid (16 pM). Data are means 
+ SE of 4 determinations. NADPH oxidase activity is 
indicated by circles, the lag time from addition of 
arachidonic acid to reaching maximal velocity (deter- 
mined as described in fig. 1) by triangles. Closed symbols 
represent pertussis toxin-treated neutrophil membranes, 
open symbols the controls. 
acid stimulates superoxide generation are 
unknown. Since arachidonic acid stimulates 
cytosolic protein kinase C [ 19,201, it has been sup- 
posed that protein kinase C may represent the 
cytosolic cofactor [lo]. According to a recent 
report, an N-protein may be involved in the activa- 
tion of membrane-associated protein kinase C, 
because GTPyS (10 PM) stimulates protein kinase 
C in membranes of rabbit peritoneal neutrophils 
[21]. On the other hand, arachidonic acid may in- 
teract directly with the neutrophil membrane, ac- 
tivating NADPH oxidase by facilitating the elec- 
tron transport from NADPH to cytochrome b _ 245 
or the interaction of the cytosolic component with 
the enzyme [22]. Therefore, at present it is not yet 
possible to explain the mechanism by which 
guanine nucleotides, in concert with arachidonic 
acid and neutrophil cytosol, stimulate superoxide 
production in human neutrophil membranes. 
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